These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1425887)

  • 1. Lack of effect of mianserin on the symptoms of diabetic neuropathy.
    Sindrup SH; Tuxen C; Gram LF; Grodum E; Skjold T; Brøsen K; Beck-Nielsen H
    Eur J Clin Pharmacol; 1992; 43(3):251-5. PubMed ID: 1425887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-stroke depression: combined treatment with imipramine or desipramine and mianserin. A controlled clinical study.
    Lauritzen L; Bendsen BB; Vilmar T; Bendsen EB; Lunde M; Bech P
    Psychopharmacology (Berl); 1994 Feb; 114(1):119-22. PubMed ID: 7846193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double-blind cross-over study.
    Sindrup SH; Gram LF; Skjold T; Grodum E; Brøsen K; Beck-Nielsen H
    Br J Clin Pharmacol; 1990 Nov; 30(5):683-91. PubMed ID: 2271367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined treatment with imipramine and mianserin. A controlled pilot study.
    Lauritzen L; Clemmesen L; Klysner R; Loldrup D; Lunde M; Schaumburg E; Waarst S; Bech P
    Pharmacopsychiatry; 1992 Jul; 25(4):182-6. PubMed ID: 1528957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms.
    Sindrup SH; Gram LF; Brøsen K; Eshøj O; Mogensen EF
    Pain; 1990 Aug; 42(2):135-144. PubMed ID: 2147235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind multicentre trial comparing mianserin with imipramine.
    Pichot P; Dreyfus JF; Pull C
    Br J Clin Pharmacol; 1978; 5 Suppl 1(Suppl 1):87S-90S. PubMed ID: 341950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imipramine treatment in diabetic neuropathy: relief of subjective symptoms without changes in peripheral and autonomic nerve function.
    Sindrup SH; Ejlertsen B; Frøland A; Sindrup EH; Brøsen K; Gram LF
    Eur J Clin Pharmacol; 1989; 37(2):151-3. PubMed ID: 2792168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imipramine treatment of painful diabetic neuropathy.
    Kvinesdal B; Molin J; Frøland A; Gram LF
    JAMA; 1984 Apr; 251(13):1727-30. PubMed ID: 6366276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A double-blind comparison between mianserin and imipramine (author's transl)].
    Pull CB; Pichot P; Dreyfus JF
    Acta Psychiatr Belg; 1978; 78(5):827-32. PubMed ID: 375686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentration-response relationship in imipramine treatment of diabetic neuropathy symptoms.
    Sindrup SH; Gram LF; Skjold T; Frøland A; Beck-Nielsen H
    Clin Pharmacol Ther; 1990 Apr; 47(4):509-15. PubMed ID: 2328559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pain relief in diabetic neuropathy: the effectiveness of imipramine and related drugs.
    Young RJ; Clarke BF
    Diabet Med; 1985 Sep; 2(5):363-6. PubMed ID: 2435449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mianserin and imipramine in the treatment of elderly depressed patients.
    Eklund K; Dunbar GC; Pinder RM; Steffensen K
    Acta Psychiatr Scand Suppl; 1985; 320():55-9. PubMed ID: 3863469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma levels and clinical response with imipramine in a study comparing efficacy with mianserin and nomifensine.
    Montgomery SA; Roy D; Wynne-Willson S; Robinson C; Montgomery DB
    Br J Clin Pharmacol; 1983; 15 Suppl 2(Suppl 2):205S-211S. PubMed ID: 6337608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy.
    Sindrup SH; Bjerre U; Dejgaard A; Brøsen K; Aaes-Jørgensen T; Gram LF
    Clin Pharmacol Ther; 1992 Nov; 52(5):547-52. PubMed ID: 1424428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of the treatment with tetracyclic and tricyclic antidepressants in patients with minor depressive disorders.
    Tudor S; Zaharia M
    Rom J Neurol Psychiatry; 1994; 32(3):185-98. PubMed ID: 7710969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nocturnal enuresis: a placebo controlled trial of two antidepressant drugs.
    Smellie JM; McGrigor VS; Meadow SR; Rose SJ; Douglas MF
    Arch Dis Child; 1996 Jul; 75(1):62-6. PubMed ID: 8813873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical study of mianserin, imipramine and placebo in depression: blood level and MHPG correlations.
    Perry GF; Fitzsimmons B; Shapiro L; Irwin P
    Br J Clin Pharmacol; 1978; 5 Suppl 1(Suppl 1):35S-41S. PubMed ID: 341942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steady-state concentrations of imipramine and its metabolites in relation to the sparteine/debrisoquine polymorphism.
    Brøsen K; Klysner R; Gram LF; Otton SV; Bech P; Bertilsson L
    Eur J Clin Pharmacol; 1986; 30(6):679-84. PubMed ID: 3533565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy.
    Max MB; Lynch SA; Muir J; Shoaf SE; Smoller B; Dubner R
    N Engl J Med; 1992 May; 326(19):1250-6. PubMed ID: 1560801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonlinear kinetics of imipramine in low and medium plasma level ranges.
    Sindrup SH; Brøsen K; Gram LF
    Ther Drug Monit; 1990 Sep; 12(5):445-9. PubMed ID: 2293406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.